Global Cord Blood (CO) Competitors $1.00 +0.10 (+11.11%) As of 09/12/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock CO vs. CORBF, MRAI, ZVRA, PRME, AGL, LAB, BCYC, EOLS, REPL, and CMPSShould you be buying Global Cord Blood stock or one of its competitors? The main competitors of Global Cord Blood include Global Cord Blood (CORBF), Marpai (MRAI), Zevra Therapeutics (ZVRA), Prime Medicine (PRME), Agilon Health (AGL), Standard BioTools (LAB), Bicycle Therapeutics (BCYC), Evolus (EOLS), Replimune Group (REPL), and COMPASS Pathways (CMPS). Global Cord Blood vs. Its Competitors Global Cord Blood Marpai Zevra Therapeutics Prime Medicine Agilon Health Standard BioTools Bicycle Therapeutics Evolus Replimune Group COMPASS Pathways Global Cord Blood (NYSE:CO) and Global Cord Blood (NYSE:CORBF) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, risk, profitability, earnings, valuation and dividends. Does the media prefer CO or CORBF? In the previous week, Global Cord Blood's average media sentiment score of 0.00 equaled Global Cord Blood'saverage media sentiment score. Company Overall Sentiment Global Cord Blood Neutral Global Cord Blood Neutral Which has more volatility and risk, CO or CORBF? Global Cord Blood has a beta of 0.16, suggesting that its share price is 84% less volatile than the S&P 500. Comparatively, Global Cord Blood has a beta of -0.59, suggesting that its share price is 159% less volatile than the S&P 500. Which has higher valuation & earnings, CO or CORBF? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGlobal Cord Blood$1.24B0.10$79.04M$0.641.56Global Cord Blood$196.12M0.62$79.04MN/AN/A Is CO or CORBF more profitable? Company Net Margins Return on Equity Return on Assets Global Cord BloodN/A N/A N/A Global Cord Blood N/A N/A N/A SummaryGlobal Cord Blood beats Global Cord Blood on 2 of the 3 factors compared between the two stocks. Get Global Cord Blood News Delivered to You Automatically Sign up to receive the latest news and ratings for CO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CO vs. The Competition Export to ExcelMetricGlobal Cord Bloodhealth & allied services, not elsewhere classified IndustryMedical SectorNYSE ExchangeMarket Cap$121.55M$84.06M$5.85B$21.59BDividend YieldN/AN/A5.68%3.48%P/E Ratio1.560.7875.3429.75Price / Sales0.100.44514.9786.29Price / Cash4.192.8037.5625.00Price / Book0.160.1612.154.58Net Income$79.04M$43.11M$3.29B$999.94M7 Day Performance-4.76%-5.91%0.75%0.68%1 Month Performance-25.93%13.85%4.82%3.10%1 Year Performance-42.86%21.66%60.59%14.39% Global Cord Blood Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)COGlobal Cord BloodN/A$1.00+11.1%N/A-30.0%$121.55M$1.24B1.561,202Gap DownCORBFGlobal Cord BloodN/A$1.05flatN/A-42.9%$127.63M$196.12M0.001,200Gap DownMRAIMarpaiN/A$1.28-4.5%N/A+117.7%$23.14M$34.87M-0.48150Gap DownZVRAZevra Therapeutics2.6813 of 5 stars$8.33-6.9%$23.71+184.7%+2.1%$502.41M$23.61M-39.6720Positive NewsAnalyst DowngradePRMEPrime Medicine3.2911 of 5 stars$3.89+4.6%$8.92+129.2%+0.5%$500.62M$4.96M-1.90234AGLAgilon Health2.8676 of 5 stars$1.26+4.6%$3.07+144.7%-67.9%$497.31M$6.06B-1.631,076LABStandard BioTools3.1462 of 5 stars$1.36+4.6%$1.55+14.0%-36.5%$496.59M$174.43M-4.25620Positive NewsInsider TradeGap UpHigh Trading VolumeBCYCBicycle Therapeutics3.6229 of 5 stars$7.00-2.2%$22.22+217.5%-74.0%$495.86M$35.28M-1.99240EOLSEvolus4.1893 of 5 stars$7.61-0.7%$21.25+179.2%-56.3%$495.49M$266.27M-7.77170Short Interest ↓REPLReplimune Group3.9174 of 5 stars$6.04-4.6%$6.50+7.6%-44.8%$494.09MN/A-1.86210Trending NewsCMPSCOMPASS Pathways3.2428 of 5 stars$4.98-3.1%$16.29+227.0%-23.3%$493.14MN/A-2.71120Positive News Related Companies and Tools Related Companies CORBF Competitors MRAI Competitors ZVRA Competitors PRME Competitors AGL Competitors LAB Competitors BCYC Competitors EOLS Competitors REPL Competitors CMPS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CO) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global Cord Blood Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Global Cord Blood With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CO Stock Alerts